UNSPSC 51112701: Carboplatin

This classification denotes a platinum compound with the molecular formula C6H6O4.Pt.2H3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BG3F62OND5, chemically known as cis-diammine(1,1-cyclobutanedicarboxylato) platinum but more generally known as carboplatin, which bears US NIH Compound Identifier 38904. European Medicines Agency schedules Carboplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06614MIG.

UNSPSC 51112701 Carboplatin, a Commodity code, covers chemotherapy pharmaceutical procurement by state and local health agencies. The recent solicitation activity under this code reflects state efforts to optimize drug acquisition and distribution through direct manufacturer relationships rather than traditional pharmacy benefit manager and wholesaler channels. State health and human services departments are the primary issuing bodies, seeking to improve cost management and prescription fulfillment efficiency for cancer treatment medications within their employee health plans and Medicaid programs.

The Texas Health and Human Services Commission issued Request for Information No. HHS0017013 on April 3, 2026, soliciting vendor capabilities for implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The RFI seeks information from potential vendors and stakeholders about establishing direct contracting relationships between the state's pharmacy benefit program and pharmaceutical manufacturers, with qualifications including vendor experience with direct contracting for self-insured employers and health plans in both private and government sectors within the past two years and capability to implement value-based or outcomes-based agreements. As an exploratory procurement mechanism, the RFI does not specify formal evaluation criteria, site visit requirements, set-aside designations, or award values; instead, it functions as foundational market intelligence to inform the state's future procurement strategy before issuing a formal Request for Proposal with established financial and temporal parameters.